{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:28:23Z","timestamp":1770812903142,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.3816\/ccc.2009.n.040","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T21:03:00Z","timestamp":1255554180000},"page":"235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trichomegaly of the Eyelashes After Colorectal Cancer Treatment With the Epidermal Growth Factor Receptor Inhibitor Cetuximab"],"prefix":"10.3816","volume":"8","author":[{"given":"Richard","family":"Bambury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"McCaffrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CCC.2009.n.040_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaad.2006.04.062","article-title":"Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients","volume":"55","author":"Roe","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CCC.2009.n.040_bib2","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/annonc\/mdi300","article-title":"Trichomegaly of the eyelashes following treatment with cetuximab","volume":"16","author":"Bouch\u00e9","year":"2005","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2009.n.040_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2230.2008.02842.x","article-title":"Trichomegaly of the eyelashes following treatment with cetuximab","volume":"34","author":"Vaccaro","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.3816\/CCC.2009.n.040_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/ICO.0b013e318166f483","article-title":"Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody)","volume":"27","author":"Foerster","year":"2008","journal-title":"Cornea"},{"key":"10.3816\/CCC.2009.n.040_bib5","first-page":"439","article-title":"Eye complications of cetuximab therapy","volume":"16","author":"Melichar","year":"2007","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.3816\/CCC.2009.n.040_bib6","first-page":"35","article-title":"Progressive trichomegaly","volume":"67","author":"Vano-Galvan","year":"2009","journal-title":"Neth J Med"},{"key":"10.3816\/CCC.2009.n.040_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/02841860310006038","article-title":"Epidermal growth factor receptor inhibition induces trichomegaly","volume":"42","author":"Dueland","year":"2003","journal-title":"Acta Oncol"},{"key":"10.3816\/CCC.2009.n.040_bib8","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2008.16.9391","article-title":"Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib","volume":"26","author":"Braiteh","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811703796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811703796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:00:33Z","timestamp":1761519633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002811703796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1533002811703796"],"URL":"https:\/\/doi.org\/10.3816\/ccc.2009.n.040","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trichomegaly of the Eyelashes After Colorectal Cancer Treatment With the Epidermal Growth Factor Receptor Inhibitor Cetuximab","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CCC.2009.n.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}